Dehydroepiandrosterone, obesity and cardiovascular disease risk: a review of human studies

Molecular Endocrinology and Oncology Research Center, Laval University Hospital Research Center (CHUL Research Center) and Laval University, Quebec G1V 4G2, Canada. andre.tchernof@crchul.ulaval.ca

The age-related decline in serum dehydroepiandrosterone (DHEA) and its sulfated ester (DHEA-S) has suggested that a relative deficiency of these steroids may be causally related to the development of chronic diseases generally associated with aging, including insulin resistance, obesity, cardiovascular disease, cancer, reductions of the immune defense, depression and a general deterioration in the sensation of well-being. The numerous studies which have focused on the link between DHEA and cardiovascular disease have generally been inconsistent, generating much debate and controversy on this issue. The present article is an analysis of studies on the relationship between endogenous DHEA or DHEA-S, obesity and cardiovascular disease risk, as well as DHEA treatment studies. Elevated plasma levels of free DHEA are associated with reduced obesity in both men and women, and with smaller abdominal body fat accumulations in men. However, contradictory results have been reported regarding the relationships between the sulfate ester DHEA-S and adiposity. Age differences in the populations studied may have been a confounding factor in these associations. On the other hand, DHEA-S level is not a predictor of cardiovascular disease endpoints in women, and appears to be a relatively weak one in men. DHEA intervention studies suggest that the effects of DHEA on serum lipids are, at best, modest or non-significant. The uncertainty as to whether endogenous and exogenous DHEA should be considered cardioprotective is related to discrepancies in the literature on this topic. Several studies may have been plagued by methodological problems such as low power, unreliable analytical methods, confounding factors or other differences in the populations studied. As a consequence, the original reports demonstrating dramatic effects of either endogenous or exogenous DHEA on cardiovascular disease risk have never been replicated. We propose that the effects of DHEA on cardiovascular disease risk (either favorable or unfavorable) should be considered to be much more modest than previously believed.

This article has been cited by other articles:

				H. Chen, A. S. Lin, Y. Li, C. E. N. Reiter, M. R. Ver, and M. J. Quon Dehydroepiandrosterone Stimulates Phosphorylation of FoxO1 in Vascular Endothelial Cells via Phosphatidylinositol 3-Kinase- and Protein Kinase A-dependent Signaling Pathways to Regulate ET-1 Synthesis and Secretion J. Biol. Chem., October 24, 2008; 283(43): 29228 - 29238. [Abstract] [Full Text] [PDF]

				P. A. Komesaroff Unravelling the Enigma of Dehydroepiandrosterone: Moving Forward Step by Step Endocrinology, March 1, 2008; 149(3): 886 - 888. [Full Text] [PDF]

				M. Giordano, M. Godi, S. Mellone, A. Petri, D. Vivenza, L. Tiradani, Y. Carlomagno, D. Ferrante, T. Arrigo, G. Corneli, et al. A Functional Common Polymorphism in the Vitamin D-Responsive Element of the GH1 Promoter Contributes to Isolated Growth Hormone Deficiency J. Clin. Endocrinol. Metab., March 1, 2008; 93(3): 1005 - 1012. [Abstract] [Full Text] [PDF]

				A. Igwebuike, B. A. Irving, M. L. Bigelow, K. R. Short, J. P. McConnell, and K. S. Nair Lack of Dehydroepiandrosterone Effect on a Combined Endurance and Resistance Exercise Program in Postmenopausal Women J. Clin. Endocrinol. Metab., February 1, 2008; 93(2): 534 - 538. [Abstract] [Full Text] [PDF]

				Z. Balazs, R. A.S. Schweizer, F. J. Frey, F. Rohner-Jeanrenaud, and A. Odermatt DHEA Induces 11 -HSD2 by Acting on CCAAT/Enhancer-Binding Proteins J. Am. Soc. Nephrol., January 1, 2008; 19(1): 92 - 101. [Abstract] [Full Text] [PDF]

				C. Roberge, A. C. Carpentier, M.-F. Langlois, J.-P. Baillargeon, J.-L. Ardilouze, P. Maheux, and N. Gallo-Payet Adrenocortical dysregulation as a major player in insulin resistance and onset of obesity Am J Physiol Endocrinol Metab, December 1, 2007; 293(6): E1465 - E1478. [Abstract] [Full Text] [PDF]

				E. Debing, E. Peeters, W. Duquet, K. Poppe, B. Velkeniers, and P. Van den Brande Endogenous sex hormone levels in postmenopausal women undergoing carotid artery endarterectomy Eur. J. Endocrinol., June 1, 2007; 156(6): 687 - 693. [Abstract] [Full Text] [PDF]

				R. Muniyappa, K. A. Wong, H. L. Baldwin, J. D. Sorkin, M. L. Johnson, S. Bhasin, S. M. Harman, and M. R. Blackman Dehydroepiandrosterone Secretion in Healthy Older Men and Women: Effects of Testosterone and Growth Hormone Administration in Older Men J. Clin. Endocrinol. Metab., November 1, 2006; 91(11): 4445 - 4452. [Abstract] [Full Text] [PDF]

				H. Filipsson, J. P. Monson, M. Koltowska-Haggstrom, A. Mattsson, and G. Johannsson The Impact of Glucocorticoid Replacement Regimens on Metabolic Outcome and Comorbidity in Hypopituitary Patients J. Clin. Endocrinol. Metab., October 1, 2006; 91(10): 3954 - 3961. [Abstract] [Full Text] [PDF]

				A. R. Cappola, Q.-L. Xue, J. D. Walston, S. X. Leng, L. Ferrucci, J. Guralnik, and L. P. Fried DHEAS Levels and Mortality in Disabled Older Women: The Women's Health and Aging Study I. J. Gerontol. A Biol. Sci. Med. Sci., September 1, 2006; 61(9): 957 - 962. [Abstract] [Full Text] [PDF]

				G. Formoso, H. Chen, J.-a Kim, M. Montagnani, A. Consoli, and M. J. Quon Dehydroepiandrosterone Mimics Acute Actions of Insulin to Stimulate Production of Both Nitric Oxide and Endothelin 1 via Distinct Phosphatidylinositol 3-Kinase- and Mitogen-Activated Protein Kinase-Dependent Pathways in Vascular Endothelium Mol. Endocrinol., May 1, 2006; 20(5): 1153 - 1163. [Abstract] [Full Text] [PDF]

				F Labrie, V Luu-The, A Belanger, S-X Lin, J Simard, G Pelletier, and C Labrie Is dehydroepiandrosterone a hormone? J. Endocrinol., November 1, 2005; 187(2): 169 - 196. [Abstract] [Full Text] [PDF]

				D. Zhang, M. Brankov, M. T. Makhija, T. Robertson, E. Helmerhorst, J. M. Papadimitriou, and P. E. Rakoczy Correlation between Inactive Cathepsin D Expression and Retinal Changes in mcd2/mcd2 Transgenic Mice Invest. Ophthalmol. Vis. Sci., September 1, 2005; 46(9): 3031 - 3038. [Abstract] [Full Text] [PDF]

				L.-A. Li and P.-W. Wang PCB126 Induces Differential Changes in Androgen, Cortisol, and Aldosterone Biosynthesis in Human Adrenocortical H295R Cells Toxicol. Sci., May 1, 2005; 85(1): 530 - 540. [Abstract] [Full Text] [PDF]

				G. Apostolova, R. A. S. Schweizer, Z. Balazs, R. M. Kostadinova, and A. Odermatt Dehydroepiandrosterone inhibits the amplification of glucocorticoid action in adipose tissue Am J Physiol Endocrinol Metab, May 1, 2005; 288(5): E957 - E964. [Abstract] [Full Text] [PDF]